Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pediatr Med Chir ; 31(2): 72-7, 2009.
Artigo em Italiano | MEDLINE | ID: mdl-19642499

RESUMO

OBJECTIVES: To know the mother's frequency with TRAb (TSH receptor antibodies) positivity during pregnancy in the population afferent to Agostino Gemelli Hospital in the five years 2002-2007 and the itself antibodies's role determining fetal and neonatal symptoms. MATERIALS AND METHODS: We performed a prospective analysis with maternal and neonatal variables detection in 16 couples mother-newborn with TRAb positivity during the pregnancy. The method to dose neonatal TRAb is ELISA (enzyme linked immunosorbant assay). RESULTS: The prevalence of newborns of mothers with TRAb positivity during pregancy results 0.1 per thousand (16/16783). The prevalence of neonatal hyperthyroidism, clinical and biochemical, in the studied population results especially elevated equal to about 30% (5/16). The 5 newborns are born to mothers with Basedow disease with TRAb serum levels greater than TRAb levels of newborn without hyperthyroidism: 2 are showed the symptoms of clinical hyperthyroidism and 3 a transient biochemical hyperthirodism. 3 newborns with hyperthyroidism among 5 are born to mother undergo thyroidectomy with L-tiroxina teraphy during the pregnancy. Then the newborns of thyroidectomized mothers also many years before the pregnancy must be considered high risk of developing neonatal hyperthyroidism because of long-lasting persistence of mother's TRAb. The neonatal hyperthyroidism, clinical and biochemical, appears later in newborns of mothers using antithyroid drugs. The pharmacological treatment of neonatal hyperthyroidism was difficult to standardize and highly individualized. CONCLUSIONS: Although the neonatal hyperthyroidism is a very rare disease it is essential to apply specific protocol assistance, both during pregnancy and the neonatal period, in the presence of maternal TRAb positive for the risk of serious cardiovascular complications.


Assuntos
Filho de Pais com Deficiência , Doenças Fetais/sangue , Doença de Graves/sangue , Imunoglobulinas Estimuladoras da Glândula Tireoide/sangue , Adulto , Biomarcadores/sangue , Ensaio de Imunoadsorção Enzimática , Feminino , Doenças Fetais/etiologia , Doenças Fetais/imunologia , Doença de Graves/complicações , Doença de Graves/tratamento farmacológico , Doença de Graves/imunologia , Doença de Graves/cirurgia , Humanos , Hipertireoidismo/sangue , Hipertireoidismo/congênito , Recém-Nascido , Masculino , Valor Preditivo dos Testes , Gravidez , Prevalência , Estudos Prospectivos , Tireoidectomia/efeitos adversos , Tiroxina/efeitos adversos , Tiroxina/uso terapêutico
2.
J Pediatr Endocrinol Metab ; 20(4): 535-9, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17550218

RESUMO

BACKGROUND: About 1-2% of infants born to mothers with Graves' disease or Hashimoto's thyroiditis develop neonatal hyperthyroidism because of transplacental passage of IgG stimulating TSH receptors (TRAb). OBJECTIVE: To evaluate the effect of maternal total thyroidectomy on neonatal clinical course. METHODS: We describe two brothers born to a mother with Graves' disease, before and after total thyroidectomy. RESULTS: The first child showed persistent tachycardia, the presence of TRAb and a laboratory pattern of hyperthyroidism. Lugol's solution was started and then propylthiouracil was added. Digitalis, furosemide and diazepam were necessary for treatment of heart failure, hypertension and irritability. On the 70th day of life, hormone serum levels normalized and treatment was interrupted. TRAb normalized by the third month of life. The second infant was born 2 years after the mother underwent total thyroidectomy. In spite of a laboratory pattern of hyperthyroidism and positivity to TRAb, he showed only considerable weight loss, and no therapy was required. CONCLUSIONS: TRAb may persist after total thyroidectomy: clinical and instrumental follow-up of the newborn is recommended.


Assuntos
Filho de Pais com Deficiência , Doença de Graves/cirurgia , Hipertireoidismo/congênito , Complicações na Gravidez/tratamento farmacológico , Irmãos , Tireoidectomia , Feminino , Doença de Graves/sangue , Doença de Graves/tratamento farmacológico , Humanos , Hipertireoidismo/sangue , Imunoglobulinas Estimuladoras da Glândula Tireoide/sangue , Recém-Nascido , Iodetos/uso terapêutico , Masculino , Avaliação de Resultados em Cuidados de Saúde , Gravidez , Tireoidectomia/efeitos adversos , Fatores de Tempo
3.
Pediatr Med Chir ; 29(2): 69-83, 2007.
Artigo em Italiano | MEDLINE | ID: mdl-17461094

RESUMO

Many studies have recently analyzed the modulation of the intestinal microflora showing a benefic effects reducing the number of enteritis, improving the oligoelements absorption and stimulating the immunitary system. To do so three way are available: the use of prebiotics, the use of probiotics and the symbiotic way. Prebiotics are non-digestible oligosaccharides that can stimulate selectively the growth bifidogenus bacteria. Probiotics are dietary supplements made of live micro-organisms which improve the microbial environment of the gut. In this review literature is examined the possible efficacy of prebiotics and probiotics in the pediatric age; however, the studies available do not permit to obtain definitive conclusions.


Assuntos
Suplementos Nutricionais , Fenômenos Fisiológicos da Nutrição do Lactente , Oligossacarídeos/uso terapêutico , Probióticos/uso terapêutico , Adulto , Fatores Etários , Estudos de Casos e Controles , Criança , Pré-Escolar , Ensaios Clínicos como Assunto , Dermatite Atópica/terapia , Diarreia Infantil/prevenção & controle , Humanos , Lactente , Alimentos Infantis , Intestinos/microbiologia , Leite Humano/química , Estado Nutricional , Valor Nutritivo , Oligossacarídeos/análise , Oligossacarídeos/fisiologia , Probióticos/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...